From 2016 -2019, the “first” PRISAR consortium implemented the first Dutch RISE project of H2020 to investigate the use of imaging technologies and hybrid fluorescence/radionuclide probes for the surgical intervention of cancer. This PRISAR project provided a career-enabling human resource plethora of inter-disciplinary and inter-sectoral secondments, which resulted in the development, of not only a hybrid probe for image-guided surgery, but also a variety of tools and instruments.
We have now been awarded of funding for a new project, PRISAR2, as coordinator of a consortium of 25 beneficiaries that will start next April 2020 and will last until March 2024.
Percuros BV is a biotech company
operating in the area of drug discovery research and optical imaging of pathways. It is working in a number of diverse areas including skeletal biology, stem cell tracking, cardiovascular biology and oncology.
Read more about us